5AM Ventures IV L.P. 13D and 13G filings for Aprea Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 5:08 pm Sale | 2021-02-11 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 30,958 13.000% | -37,925 (-55.06%) | Filing |
| 2020-11-19 4:27 pm Sale | 2020-11-16 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 68,883 6.500% | -33,000 (-32.39%) | Filing |
| 2020-10-07 5:00 pm Sale | 2020-10-05 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 101,883 9.600% | -15,750 (-13.39%) | Filing |
| 2020-06-15 7:13 pm Sale | 2020-06-11 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 117,633 11.200% | -12,250 (-9.43%) | Filing |
| 2020-05-21 8:38 pm Sale | 2020-05-19 | 13D | Aprea Therapeutics, Inc. APRE | 5AM Ventures IV L.P. | 129,883 12.300% | -12,750 (-8.94%) | Filing |